Identification of responsible gene of bone metastasis in prostate cancer and its treatment using a recombinant HSV
Project/Area Number |
18591778
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Osaka Medical College |
Principal Investigator |
KATSUOKA Yoji Osaka Medical College, 医学部, 教授 (10051757)
|
Co-Investigator(Kenkyū-buntansha) |
AZUMA Haruhito 大阪医科大学, 医学部, 准教授 (40231914)
|
Project Period (FY) |
2006 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥660,000)
Fiscal Year 2009: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2008: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2007: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
Keywords | HSV / 前立腺癌 / PSM / サバイビン / splice variants |
Research Abstract |
1) We have been developing the recombinant HSV, which has the promotor region targeted on prostate specific membrane (PSM). 2) We have found that one of the two splice variant of surviving, survivin-Ex3 has a positive, and the other splice variant survivin-2B has a negative correlation with histological grade. 3) We have been developing the recombinant HSV, which has the promotor region targeted on Survivin-Ex3.
|
Report
(6 results)
Research Products
(16 results)
-
[Journal Article] Conversion of Prostate Cancer from Hormone Independency to Dependency Due to AMACR Inhibition: Involvement of Increased AR Expression and Decreased IGF1 Expression.2009
Author(s)
Takahara K, Azuma H, Sakamoto T, Kiyama S, Inamoto T, Ibuki N, Nishida T, Nomi H, Ubai T, Sagawa N, Katsuoka Y.
-
Journal Title
Anticancer Research 29
Pages: 2497-2506
Related Report
-
-
-
[Journal Article] Conversion of Prostate Cancer from Hormone Independency to Dependency Due to AMACR Inhibition : Involvement of Increased AR Expression and Decreased IGF1 Expression2009
Author(s)
Takahara K, Azuma H, Sakamoto T, Kiyama S, Inamoto T, Ibuki N, Nishida T, Nomi H, Ubai T, Sagawa N, Katsuoka Y.
-
Journal Title
Anticancer Research 29
Pages: 2497-2506
Related Report
Peer Reviewed
-
-
-
[Journal Article] Marked regression of liver metastasis by combined therapy of ulrtasound-mediated NFkB-decoy transfer and transportal injection of paclitaxel, in mouse2008
Author(s)
Azuma H, Tomita N, SakamotoT, Kiyama S, Inamoto T, Takahara K, Kotake Y, Segawa N, Morishita R, Taorie S, Tanigawa N, Katsuoka Y.
-
Journal Title
Int.J.Cancer 122
Pages: 1645-1656
Related Report
Peer Reviewed
-
[Journal Article] Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelima Tumors2007
Author(s)
Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, Inamoto S, Katsuoka Y, Hosono O, Tanaka H, Dang NH, Morimoto C.
-
Journal Title
Clin Cancer Res 13
Pages: 4191-4200
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Anti-CD26 Monoclonal Antibody-Mediated G1-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27kipl Enhancement, and Disruption of Binding to the Extracellular Matrix.2006
Author(s)
T.Inamoto, T.Yamochi, K.Ohnuma, S, Iwata, S, Kina, S, Inamoto, M.Tachibana, Y.Katsuoka, Nam H.Dang, C, Morimoto
-
Journal Title
Clin Cancer Res 12・11
Pages: 3470-3477
Related Report
-
-
-